The Medicines and Healthcare products Regulatory Agency (MHRA) has approved a change to the license of the Comirnaty Omicron XBB.1.5 30 micrograms/dose (single-dose vials) after it was found to meet the UK regulator’s standards of safety, quality and effectiveness.
AVEO Pharmaceuticals Inc Patent: Decreasing Blood Urea Nitrogen Levels in Hyperuricemia
Share this article According to GlobalData’s company profile on AVEO Pharmaceuticals, was a key innovation area identified from patents. Decreasing blood urea nitrogen levels in